Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function

Neurogastroenterology and Motility

Volumn 21, Issue 12, 2009, Pages 1239-1249

  Keszthelyi, D ^a,b   Troost, F J ^a,b   Masclee, A A M ^a,b  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Gastrointestinal function; Kynurenine; Nutritional modulation; Serotonin; Tryptophan

Indexed keywords

5 HYDROXYINDOLE DERIVATIVE; 5 HYDROXYINDOLE THIAZOLIDINE CARBOXYLIC ACID; 5 HYDROXYINDOLEACETALDEHYDE; 5 HYDROXYTRYPTOPHAN; 5 HYDROXYTRYPTOPHOL; ACRYLIC ACID DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; FENCLONINE; GLUTAMINE DERIVATIVE; GLYCINE DERIVATIVE; INDICAN; INDOLE; INDOLE DERIVATIVE; INDOLEACETIC ACID; INDOLEACRYLIC ACID; INDOLYLACETYLGLUTAMINE; INDOLYLACRYLOYLGLYCINE; INDOLYLLACTIC ACID; INDOLYLPROPIONIC ACID; KYNURENINE; LACTIC ACID DERIVATIVE; NICOTINAMIDE; PROPIONIC ACID DERIVATIVE; QUINOLINIC ACID; SEROTONIN; TRYPTOPHAN; UNCLASSIFIED DRUG; XANTHURENIC ACID;

ALZHEIMER DISEASE; BIOTRANSFORMATION; CELIAC DISEASE; DIARRHEA; DIET SUPPLEMENTATION; DISEASE SEVERITY; DIVERTICULITIS; DRUG ABSORPTION; DRUG EXCRETION; DRUG METABOLISM; DRUG URINE LEVEL; ENTERITIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT FUNCTION; HUMAN; INTESTINE; INTESTINE FUNCTION; IRRITABLE COLON; MALABSORPTION; MOTONEURON; NEUROMODULATION; NUTRITION; OXIDATION REDUCTION REACTION; PATHOGENESIS; PELLAGRA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW; SEROTONIN METABOLISM; SIGNAL TRANSDUCTION; TRYPTOPHAN METABOLISM;

ANIMALS; BACTERIA; DIGESTIVE SYSTEM PHYSIOLOGICAL PHENOMENA; GASTROINTESTINAL DISEASES; HUMANS; INTESTINES; KYNURENINE; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; SEROTONIN; TRYPTOPHAN;

EID: 72449121934     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2009.01370.x     Document Type: Review

References (59)

1. Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007 132 : 397 414.
2. Lesurtel M, Soll C, Graf R, Clavien PA. Role of serotonin in the hepato-gastroIntestinal tract: an old molecule for new perspectives. Cell Mol Life Sci 2008 65 : 940 952.
3. Peters JC. Tryptophan nutrition and metabolism: an overview. Adv Exp Med Biol 1991 294 : 345 358.
4. Broer S. Amino acid transport across mammalian intestinal and renal epithelia. Physiol Rev 2008 88 : 249 286.
5. Drummond KN, Michael AF, Ulstrom RA, Good RA. The blue diaper syndrome: familial hypercalcemia with nephrocalcinosis and indicanuria; a new familial disease, with definition of the metabolic abnormality. Am J Med 1964 37 : 928 948.
6. Fernstrom JD. Branched-chain amino acids and brain function. J Nutr 2005 135 : 1539S 46S.
7. Allegri G, Costa CV, Bertazzo A, Biasiolo M, Ragazzi E. Enzyme activities of tryptophan metabolism along the kynurenine pathway in various species of animals. Farmaco 2003 58 : 829 836.
8. Bender DA. Biochemistry of tryptophan in health and disease. Mol Aspects Med 1983 6 : 101 197.
9. Walther DJ, Peter JU, Bashammakh S et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003 299 : 76.
10. Chang YT, Mues G, Hyland K. Alternative splicing in the coding region of human aromatic L-amino acid decarboxylase mRNA. Neurosci Lett 1996 202 : 157 160.
11. Rindi G, Leiter AB, Kopin AS, Bordi C, Solcia E. The "normal" endocrine cell of the gut: changing concepts and new evidences. Ann NY Acad Sci 2004 1014 : 1 12.
12. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003 97 : 934 959.
13. Oates JA, Sjoerdsma A. A unique syndrome associated with secretion of 5-hydroxytryptophan by metastatic gastric carcinoids. Am J Med 1962 32 : 333 342.
14. Alfieri AB, Cubeddu LX. Treatment with para-chlorophenylalanine antagonises the emetic response and the serotonin-releasing actions of cisplatin in cancer patients. Br J Cancer 1995 71 : 629 632.
15. Shi ZC, Devasagayaraj A, Gu K et al. Modulation of peripheral serotonin levels by novel tryptophan hydroxylase inhibitors for the potential treatment of functional gastrointestinal disorders. J Med Chem 2008 51 : 3684 3687.
16. Young HM, Furness JB. Ultrastructural examination of the targets of serotonin-immunoreactive descending interneurons in the guinea pig small intestine. J Comp Neurol 1995 356 : 101 114.
17. Neal KB, Bornstein JC. Mapping 5-HT inputs to enteric neurons of the guinea-pig small intestine. Neuroscience 2007 145 : 556 567.
18. Billett EE. Monoamine oxidase (MAO) in human peripheral tissues. Neurotoxicology 2004 25 : 139 148.
19. Kema IP, de Vries EG, Muskiet FA. Clinical chemistry of serotonin and metabolites. J Chromatogr B Biomed Sci Appl 2000 747 : 33 48.
20. Kohle C, Badary OA, Nill K, Bock-Hennig BS, Bock KW. Serotonin glucuronidation by Ah receptor- and oxidative stress-inducible human UDP-glucuronosyltransferase (UGT) 1A6 in Caco-2 cells. Biochem Pharmacol 2005 69 : 1397 1402.
21. Munzel PA, Bookjans G, Mehner G, Lehmkoster T, Bock KW. Tissue-specific 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible expression of human UDP-glucuronosyltransferase UGT1A6. Arch Biochem Biophys 1996 335 : 205 210.
22. Radominska-Pandya A, Little JM, Pandya JT et al. UDP- glucuronosyltransferases in human intestinal mucosa. Biochim Biophys Acta 1998 1394 : 199 208.
23. Squires LN, Jakubowski JA, Stuart JN et al. Serotonin catabolism and the formation and fate of 5-hydroxyindole thiazolidine carboxylic acid. J Biol Chem 2006 281 : 13463 13470.
24. Mawe GM, Coates MD, Moses PL. Review article: intestinal serotonin signaling in irritable bowel syndrome. Aliment Pharmacol Ther 2006 23 : 1067 1076.
25. van der Veek PP, Van Rood YR, Masclee AA. Symptom severity but not psychopathology predicts visceral hypersensitivity in irritable bowel syndrome. Clin Gastroenterol Hepatol 2008 6 : 321 328.
26. Ait-Belgnaoui A, Bradesi S, Fioramonti J, Theodorou V, Bueno L. Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: role of myosin light chain kinase. Pain 2005 113 : 141 147.
27. Stone TW, Darlington LG. Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 2002 1 : 609 620.
28. Moffett JR, Namboodiri MA. Tryptophan and the immune response. Immunol Cell Biol 2003 81 : 247 265.
29. Yamazaki F, Kuroiwa T, Takikawa O, Kido R. Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme. Biochem J 1985 230 : 635 638.
30. Wolf AM, Wolf D, Rumpold H et al. Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin Immunol 2004 113 : 47 55.
31. Torres MI, Lopez-Casado MA, Lorite P, Rios A. Tryptophan metabolism and indoleamine 2,3-dioxygenase expression in coeliac disease. Clin Exp Immunol 2007 148 : 419 424.
32. Ferdinande L, Demetter P, Perez-Novo C et al. Inflamed intestinal mucosa features a specific epithelial expression pattern of indoleamine 2,3-dioxygenase. Int J Immunopathol Pharmacol 2008 21 : 289 295.
33. Uyttenhove C, Pilotte L, Theate I et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 2003 9 : 1269 1274.
34. Kaszaki J, Palasthy Z, Erczes D et al. Kynurenic acid inhibits intestinal hypermotility and xanthine oxidase activity during experimental colon obstruction in dogs. Neurogastroenterol Motil 2008 20 : 53 62.
35. Forrest CM, Gould SR, Darlington LG, Stone TW. Levels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease. Adv Exp Med Biol 2003 527 : 395 400.
36. Kirchgessner AL. Glutamate in the enteric nervous system. Curr Opin Pharmacol 2001 1 : 591 596.
37. Slattery JA, Page AJ, Dorian CL, Brierley SM, Blackshaw LA. Potentiation of mouse vagal afferent mechanosensitivity by ionotropic and metabotropic glutamate receptors. J Physiol 2006 577 : 295 306.
38. Hayaishi O. Properties and function of indoleamine 2,3-dioxygenase. J Biochem 1976 79 : 13P 21P.
39. Smith EA, Macfarlane GT. Formation of Phenolic and Indolic Compounds by Anaerobic Bacteria in the Human Large Intestine. Microb Ecol 1997 33 : 180 188.
40. Wikoff WR, Anfora AT, Liu J et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA 2009 106 : 3698 3703.
41. Stott A, Khan M, Roberts C, Galpin IJ. Purple urine bag syndrome. Ann Clin Biochem 1987 2 : 185 188.
42. Marklova E. Where does indolylacrylic acid come from? Amino Acids 1999 17 : 401 413.
43. Haverback BJ, Dyce B, Thomas HV. Indole metabolism in the malabsorption syndrome. N Engl J Med 1960 262 : 754 757.
44. Nowak A, Libudzisz Z. Influence of phenol, p-cresol and indole on growth and survival of intestinal lactic acid bacteria. Anaerobe 2006 12 : 80 4.
45. Bull G, Shattock P, Whiteley P et al. Indolyl-3-acryloylglycine (IAG) is a putative diagnostic urinary marker for autism spectrum disorders. Med Sci Monit 2003 9 : CR422 5.
46. D'Eufemia P, Celli M, Finocchiaro R et al. Abnormal intestinal permeability in children with autism. Acta Paediatr 1996 85 : 1076 1079.
47. Wright B, Brzozowski AM, Calvert E et al. Is the presence of urinary indolyl-3-acryloylglycine associated with autism spectrum disorder? Dev Med Child Neurol 2005 47 : 190 192.
48. Liebregts T, Adam B, Bredack C et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007 132 : 913 920.
49. Fitzgerald P, Cassidy Eugene M, Clarke G et al. Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity. Neurogastroenterol Motil 2008 20 : 1291 1297.
50. Clarke G, Fitzgerald P, Cryan JF, Cassidy EM, Quigley EM, Dinan TG. Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort. BMC Gastroenterol 2009 9 : 6.
51. Kim DY, Camilleri M. Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol 2000 95 : 2698 2709.
52. Gruninger TR, LeBoeuf B, Liu Y, Garcia LR. Molecular signaling involved in regulating feeding and other motivated behaviors. Mol Neurobiol 2007 35 : 1 20.
53. Shufflebotham J, Hood S, Hendry J et al. Acute tryptophan depletion alters gastrointestinal and anxiety symptoms in irritable bowel syndrome. Am J Gastroenterol 2006 101 : 2582 2587.
54. Kilkens TO, Honig A, van Nieuwenhoven MA, Riedel WJ, Brummer RJ. Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls. Gut 2004 53 : 1794 1800.
55. Agazzi A, De Ponti F, De Giorgio R et al. Review of the implications of dietary tryptophan intake in patients with irritable bowel syndrome and psychiatric disorders. Dig Liver Dis 2003 35 : 590 595.
56. Markus CR, Jonkman LM, Lammers JH, Deutz NE, Messer MH, Rigtering N. Evening intake of alpha-lactalbumin increases plasma tryptophan availability and improves morning alertness and brain measures of attention. Am J Clin Nutr 2005 81 : 1026 1033.
57. Attenburrow MJ, Williams C, Odontiadis J et al. The effect of a nutritional source of tryptophan on dieting-induced changes in brain 5-HT function. Psychol Med 2003 33 : 1381 1386.
58. Miura H, Ozaki N, Sawada M, Isobe K, Ohta T, Nagatsu T. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress 2008 11 : 198 209.
59. Turski MP, Turska M, Zgrajka W, Kuc D, Turski WA. Presence of kynurenic acid in food and honeybee products. Amino Acids 2009 36 : 75 80.